As of 2025-09-16, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (22.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -158.2%.
The range of the Relative Valuation is (17.87) - (25.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 15.3x | 13.6x |
| Forward P/E multiples | 10.8x - 16.8x | 13.5x |
| Fair Price | (17.87) - (25.20) | (22.26) |
| Upside | -146.8% - -165.9% | -158.2% |
| Date | P/E |